Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Rottapharm Biotech S.r.l.

Italy Via Valosa Di Sopra 9, 20900 Monza, Italy

About the sponsor

Rottapharm Biotech S.r.l. is active in metastatic colorectal cancer, with a focus on mismatch-repair-proficient and microsatellite stable disease after prior treatment.

  • pMMR and MSS metastatic colorectal cancer
  • Pretreated advanced gastrointestinal malignancy
  • Immuno-oncology combinations

The sponsor’s research interest in this area centres on advanced colorectal cancer where standard immune responsiveness is limited, with attention to therapeutic strategies that may expand treatment options in resistant disease.

About Specializations

Rottapharm Biotech S.r.l. runs clinical trials in conditions such as Colorectal cancer metastatic, Gastrointestinal cancer metastatic, Mismatch repair cancer syndrome, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Colorectal cancer metastatic+2

Not recruiting

Study on the Safety and Efficacy of CR6086 and Balstilimab for Patients with Pretreated Metastatic Colorectal and Other GI Cancers

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Balstilimab
  • Sponsor:Rottapharm Biotech S.r.l.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.